Gene-based Advanced Therapy Medical Product Market - Global Outlook and Forecast 2021-2027
Report Code: KNJ759047 No. of Pages: 94 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
The Gene-based Advanced Therapy Medical Product market report provides the overall market analysis of the industry. This market report presents the current snapshot of the Gene-based Advanced Therapy Medical Product market to understand the market's key features. The content of the report highlights the important market criteria that help to develop the market further. The report provides the value and the volume of the Gene-based Advanced Therapy Medical Product at global, regional, and company levels. The historical market value for the year 2021 along with the market value for the upcoming year 2027 has been presented in the market report. Along with that, the report also provides information on subjects such as Export, import, production, and production capacity of the Gene-based Advanced Therapy Medical Product market.This report contains market size and forecasts of Gene-based Advanced Therapy Medical Product in Global, including the following market information: Global Gene-based Advanced Therapy Medical Product Market Revenue, 2016-2021, 2022-2027, ($ millions) Global top five companies in 2020 (%) The global Gene-based Advanced Therapy Medical Product market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene-based Advanced Therapy Medical Product companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Gene-based Advanced Therapy Medical Product Market, By Type, 2016-2021, 2022-2027 ($ millions) Global Gene-based Advanced Therapy Medical Product Market Segment Percentages, By Type, 2020 (%) Viral Gene Delivery System Non-viral Gene Delivery System China Gene-based Advanced Therapy Medical Product Market, By Application, 2016-2021, 2022-2027 ($ millions) China Gene-based Advanced Therapy Medical Product Market Segment Percentages, By Application, 2020 (%) Neurological Diseases Cancer Other Global Gene-based Advanced Therapy Medical Product Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) Global Gene-based Advanced Therapy Medical Product Market Segment Percentages, By Region and Country, 2020 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Total Gene-based Advanced Therapy Medical Product Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions) Total Gene-based Advanced Therapy Medical Product Market Competitors Revenues Share in Global, by Players 2020 (%) Further, the report presents profiles of competitors in the market, including the following: Biogen Novartis Gilead Sciences Sarepta Therapeutics Alnylam Pharmaceuticals Amgen Spark Therapeutics Akcea Therapeutics bluebird bio Sunway Biotech SIBIONO AnGes Orchard Therapeutics Human Stem Cells Institute
1 Introduction to Research & Analysis Reports
1.1 Gene-based Advanced Therapy Medical Product Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene-based Advanced Therapy Medical Product Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene-based Advanced Therapy Medical Product Overall Market Size
2.1 Global Gene-based Advanced Therapy Medical Product Market Size: 2021 VS 2027
2.2 Global Gene-based Advanced Therapy Medical Product Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene-based Advanced Therapy Medical Product Players in Global Market
3.2 Top Global Gene-based Advanced Therapy Medical Product Companies Ranked by Revenue
3.3 Global Gene-based Advanced Therapy Medical Product Revenue by Companies
3.4 Top 3 and Top 5 Gene-based Advanced Therapy Medical Product Companies in Global Market, by Revenue in 2020
3.5 Global Companies Gene-based Advanced Therapy Medical Product Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene-based Advanced Therapy Medical Product Players in Global Market
3.6.1 List of Global Tier 1 Gene-based Advanced Therapy Medical Product Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene-based Advanced Therapy Medical Product Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene-based Advanced Therapy Medical Product Market Size Markets, 2021 & 2027
4.1.2 Viral Gene Delivery System
4.1.3 Non-viral Gene Delivery System
4.2 By Type - Global Gene-based Advanced Therapy Medical Product Revenue & Forecasts
4.2.1 By Type - Global Gene-based Advanced Therapy Medical Product Revenue, 2016-2021
4.2.2 By Type - Global Gene-based Advanced Therapy Medical Product Revenue, 2022-2027
4.2.3 By Type - Global Gene-based Advanced Therapy Medical Product Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene-based Advanced Therapy Medical Product Market Size, 2021 & 2027
5.1.2 Neurological Diseases
5.1.3 Cancer
5.1.4 Other
5.2 By Application - Global Gene-based Advanced Therapy Medical Product Revenue & Forecasts
5.2.1 By Application - Global Gene-based Advanced Therapy Medical Product Revenue, 2016-2021
5.2.2 By Application - Global Gene-based Advanced Therapy Medical Product Revenue, 2022-2027
5.2.3 By Application - Global Gene-based Advanced Therapy Medical Product Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Gene-based Advanced Therapy Medical Product Market Size, 2021 & 2027
6.2 By Region - Global Gene-based Advanced Therapy Medical Product Revenue & Forecasts
6.2.1 By Region - Global Gene-based Advanced Therapy Medical Product Revenue, 2016-2021
6.2.2 By Region - Global Gene-based Advanced Therapy Medical Product Revenue, 2022-2027
6.2.3 By Region - Global Gene-based Advanced Therapy Medical Product Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Gene-based Advanced Therapy Medical Product Revenue, 2016-2027
6.3.2 US Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.3.3 Canada Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.3.4 Mexico Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Gene-based Advanced Therapy Medical Product Revenue, 2016-2027
6.4.2 Germany Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.4.3 France Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.4.4 U.K. Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.4.5 Italy Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.4.6 Russia Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.4.7 Nordic Countries Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.4.8 Benelux Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Gene-based Advanced Therapy Medical Product Revenue, 2016-2027
6.5.2 China Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.5.3 Japan Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.5.4 South Korea Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.5.5 Southeast Asia Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.5.6 India Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Gene-based Advanced Therapy Medical Product Revenue, 2016-2027
6.6.2 Brazil Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.6.3 Argentina Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene-based Advanced Therapy Medical Product Revenue, 2016-2027
6.7.2 Turkey Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.7.3 Israel Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.7.4 Saudi Arabia Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
6.7.5 UAE Gene-based Advanced Therapy Medical Product Market Size, 2016-2027
7 Players Profiles
7.1 Biogen
7.1.1 Biogen Corporate Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Gene-based Advanced Therapy Medical Product Major Product Offerings
7.1.4 Biogen Gene-based Advanced Therapy Medical Product Revenue in Global (2016-2021)
7.1.5 Biogen Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Gene-based Advanced Therapy Medical Product Major Product Offerings
7.2.4 Novartis Gene-based Advanced Therapy Medical Product Revenue in Global (2016-2021)
7.2.5 Novartis Key News
7.3 Gilead Sciences
7.3.1 Gilead Sciences Corporate Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Gene-based Advanced Therapy Medical Product Major Product Offerings
7.3.4 Gilead Sciences Gene-based Advanced Therapy Medical Product Revenue in Global (2016-2021)
7.3.5 Gilead Sciences Key News
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Corporate Summary
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Major Product Offerings
7.4.4 Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Revenue in Global (2016-2021)
7.4.5 Sarepta Therapeutics Key News
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Corporate Summary
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Major Product Offerings
7.5.4 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Revenue in Global (2016-2021)
7.5.5 Alnylam Pharmaceuticals Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Gene-based Advanced Therapy Medical Product Major Product Offerings
7.6.4 Amgen Gene-based Advanced Therapy Medical Product Revenue in Global (2016-2021)
7.6.5 Amgen Key News
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Corporate Summary
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Gene-based Advanced Therapy Medical Product Major Product Offerings
7.4.4 Spark Therapeutics Gene-based Advanced Therapy Medical Product Revenue in Global (2016-2021)
7.7.5 Spark Therapeutics Key News
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Corporate Summary
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medical Product Major Product Offerings
7.8.4 Akcea Therapeutics Gene-based Advanced Therapy Medical Product Revenue in Global (2016-2021)
7.8.5 Akcea Therapeutics Key News
7.9 bluebird bio
7.9.1 bluebird bio Corporate Summary
7.9.2 bluebird bio Business Overview
7.9.3 bluebird bio Gene-based Advanced Therapy Medical Product Major Product Offerings
7.9.4 bluebird bio Gene-based Advanced Therapy Medical Product Revenue in Global (2016-2021)
7.9.5 bluebird bio Key News
7.10 Sunway Biotech
7.10.1 Sunway Biotech Corporate Summary
7.10.2 Sunway Biotech Business Overview
7.10.3 Sunway Biotech Gene-based Advanced Therapy Medical Product Major Product Offerings
7.10.4 Sunway Biotech Gene-based Advanced Therapy Medical Product Revenue in Global (2016-2021)
7.10.5 Sunway Biotech Key News
7.11 SIBIONO
7.11.1 SIBIONO Corporate Summary
7.11.2 SIBIONO Business Overview
7.11.3 SIBIONO Gene-based Advanced Therapy Medical Product Major Product Offerings
7.11.4 SIBIONO Gene-based Advanced Therapy Medical Product Revenue in Global (2016-2021)
7.11.5 SIBIONO Key News
7.12 AnGes
7.12.1 AnGes Corporate Summary
7.12.2 AnGes Business Overview
7.12.3 AnGes Gene-based Advanced Therapy Medical Product Major Product Offerings
7.12.4 AnGes Gene-based Advanced Therapy Medical Product Revenue in Global (2016-2021)
7.12.5 AnGes Key News
7.13 Orchard Therapeutics
7.13.1 Orchard Therapeutics Corporate Summary
7.13.2 Orchard Therapeutics Business Overview
7.13.3 Orchard Therapeutics Gene-based Advanced Therapy Medical Product Major Product Offerings
7.13.4 Orchard Therapeutics Gene-based Advanced Therapy Medical Product Revenue in Global (2016-2021)
7.13.5 Orchard Therapeutics Key News
7.14 Human Stem Cells Institute
7.14.1 Human Stem Cells Institute Corporate Summary
7.14.2 Human Stem Cells Institute Business Overview
7.14.3 Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Major Product Offerings
7.14.4 Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Revenue in Global (2016-2021)
7.14.5 Human Stem Cells Institute Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com